Menopause Completed Phase 2 / 3 Trials for Teriparatide (DB06285)

Also known as: Menopausal

IndicationStatusPhase
DBCOND0025857 (Menopause)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00697463Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal WomenTreatment